ASND vs. AZN: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ASND and AZN, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AZN stands out with 432.07 billion USD in market value—about 45.27× ASND’s market cap of 9.55 billion USD.
ASND’s beta of 0.40 points to much larger expected swings compared to AZN’s calmer 0.18, suggesting both higher upside and downside potential.
ASND and AZN are both ADRs—easy access for U.S. investors to foreign shares without dealing with overseas exchanges.
Symbol | ASND | AZN |
---|---|---|
Company Name | Ascendis Pharma A/S | AstraZeneca PLC |
Country | DK | GB |
Sector | Healthcare | Healthcare |
Industry | Biotechnology | Drug Manufacturers - General |
CEO | Mr. Jan Moller Mikkelsen | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. |
Price | 158.1 USD | 69.68 USD |
Market Cap | 9.55 billion USD | 432.07 billion USD |
Beta | 0.40 | 0.18 |
Exchange | NASDAQ | NASDAQ |
IPO Date | January 28, 2015 | May 12, 1993 |
ADR | Yes | Yes |
Performance Comparison
This chart compares the performance of ASND and AZN over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ASND and AZN based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- ASND posts a negative P/E of -24.55, reflecting last year’s net loss, while AZN at 27.76 signals healthy earnings.
- ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas AZN at 2.49 has projections for stable or growing earnings.
- ASND has a negative P/B ratio of -44.20, indicating its liabilities exceed assets (negative equity). AZN, with a P/B of 5.26, maintains positive shareholder equity.
- ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, AZN (P/FCF 22.30) indicates positive free cash flow generation.
Symbol | ASND | AZN |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | -24.55 | 27.76 |
Forward PEG Ratio (TTM) | -2.23 | 2.49 |
Price-to-Sales Ratio (P/S, TTM) | 22.89 | 3.93 |
Price-to-Book Ratio (P/B, TTM) | -44.20 | 5.26 |
Price-to-Free Cash Flow Ratio (P/FCF, TTM) | -27.43 | 22.30 |
EV-to-EBITDA (TTM) | -35.74 | 13.67 |
EV-to-Sales (TTM) | 23.78 | 4.41 |
EV-to-Free Cash Flow (TTM) | -28.50 | 25.04 |
Dividend Comparison
ASND offers a 0% dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while AZN provides a 1.39% dividend yield, giving investors a steady income stream.
Symbol | ASND | AZN |
---|---|---|
Dividend Yield (TTM) | 0.00% | 1.39% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ASND and AZN, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AZN’s current ratio of 0.90 indicates its assets may not cover near-term debts, whereas ASND at 1.04 maintains healthy liquidity.
- Both ASND (quick ratio 0.71) and AZN (quick ratio 0.70) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- ASND has negative equity (debt-to-equity ratio -4.46), an unusual warning sign, while AZN at 0.77 maintains a conventional debt-to-equity balance.
- With negative EBIT (-3.72), ASND cannot cover its interest payments. AZN, with an interest coverage of 7.95, meets its interest obligations.
Symbol | ASND | AZN |
---|---|---|
Current Ratio (TTM) | 1.04 | 0.90 |
Quick Ratio (TTM) | 0.71 | 0.70 |
Debt-to-Equity Ratio (TTM) | -4.46 | 0.77 |
Debt-to-Assets Ratio (TTM) | 0.80 | 0.30 |
Interest Coverage Ratio (TTM) | -3.72 | 7.95 |